Skip to main content
MNKD
NASDAQ Life Sciences

MannKind Reports $16.6M Loss for First Quarter

feedReported by Dow Jones Newswires
Sentiment info
Negative
Importance info
7
Price
$3.6
Mkt Cap
$1.099B
52W Low
$2.23
52W High
$6.51
Market data snapshot near publication time

summarizeSummary

MannKind Corporation announced a net loss of $16.6 million for its first quarter. This financial update provides new insight into the company's performance for Q1 2026, following its fiscal year 2025 10-K filing in February. A specific quarterly loss figure from a Tier 1 wire service is material information that professional traders would need to assess immediately, as it can directly impact investor sentiment and stock valuation. Investors will now focus on the full earnings report for detailed explanations of the loss and any forward guidance.

At the time of this announcement, MNKD was trading at $3.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $2.23 to $6.51. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed MNKD - Latest Insights

MNKD
May 06, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
MNKD
May 06, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
MNKD
May 06, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
MNKD
Mar 10, 2026, 9:30 PM EDT
Filing Type: 4
Importance Score:
7
MNKD
Feb 26, 2026, 8:06 AM EST
Filing Type: 10-K
Importance Score:
8
MNKD
Feb 26, 2026, 8:03 AM EST
Filing Type: 8-K
Importance Score:
7